You searched for "TINNET"

422 results found

New sites needed for STARFISH trial

The STARFISH Trial is aiming to recruit 525 participants with sudden hearing loss from 75 ENT departments treating idiopathic sudden sensorineural hearing loss (ISSNHL).

34th Politzer Society Meeting

The latest Politzer Society meeting has just taken place in Rome between the 13 and 16 October 2024, led by its president, Professor Maurizio Barbara. The Politzer Society is an international scientific organisation whose objective is the dissemination of knowledge in the field of otology and neurotology worldwide.

Steroid use in acute acoustic trauma

Acute acoustic trauma (AAT) injuries include noise-induced damage to inner and middle ear presenting as hearing loss, tinnitus and vertigo. Classic presentation is sensorineural hearing loss with an intact tympanic membrane. The authors carried out a case-control study in military...

Outcomes of larger glottic cancer volumes treated with radiotherapy

T3 glottic cancer is characterised as vocal cord fixation and/or invasion into pre-epiglottic, post-cricoid, paraglottic spaces and/or within the inner cortex of thyroid cartilage. Traditionally, laryngectomy was considered the primary option to treat T3 laryngeal glottic cancers until other options...

Case study suggesting mtDNA mutation as a tinnitus factor: ND1:m.3394T>C

Konadath et al report a genetic case study of a 24-year-old female experiencing reduced hearing sensitivity and tinnitus along with a blocked sensation in her right ear, sudden onset one year prior with no other otological complaints. Standard audiometry along...

Recruitment of Sudden Hearing Loss Patients for Clinical Trial: Novel Compound AC102 Outperforms Corticosteroids Preclinically

While corticosteroids are widely used to treat Sudden Sensorineural Hearing Loss (SSNHL), there is still no therapy with proven efficacy and regulatory approval for this debilitating condition.

The future of treatments for hearing and balance: a 15 and 50-year perspective

Jameel Muzaffar and Manohar Bance paint a picture of what otology will look like 15 and 50 years’ time. Will we still need doctors? Will there still be an ENT news journal? The last 50 years have seen advances including...

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.

Hearing matters in New Year's Honours

Emeritus Professor David Kemp from the UCL Ear Institute, widely known for his discovery of otoacoustic emissions, has been made a CBE for services to auditory sciences and public health. Robert Nolan, chair of Deafblind UK, was awarded OBE for services to people living with deafblindness.

What’s new in laryngology: the next 10 years!

At a time of unprecedented technological advances, Taran Tatla and Jonathan Fishman gaze into the laryngological crystal ball… Introduction The recent explosion in science, technology and innovation takes us into a new era, with the opportunity and capability to transform...

Developing an Innovation for ENT – from Idea to Market: how ‘e-i’ did it

Background endoscope-i (e-i) Ltd was incorporated into Companies House on December 3rd, 2012 following eight months of developing our first project, a simple iPhone adapter for endoscopes. Of the three founding shareholders, two are ENT surgeons and one a lecturer...

Centenary birthday of Jean-Marc Sterkers: pioneer of vestibular schwannoma surgery

Professor Jean-Marc Sterkers has been a leading figure in the field of otology and neurotology for several decades. On the verge of his 100th birthday, we celebrate an exceptional career through the memories of his son and colleagues. Prof Olivier...